| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 24.959 | 22.475 | 23.829 | 30.206 | 26.841 | 15.056 | 16.740 | 9.174 | 18.257 | 0 |
| Total Income - EUR | 24.972 | 22.477 | 23.829 | 38.802 | 26.841 | 15.056 | 16.740 | 9.174 | 18.257 | 0 |
| Total Expenses - EUR | 25.497 | 25.483 | 22.133 | 14.175 | 19.792 | 19.820 | 30.097 | 29.205 | 22.984 | 0 |
| Gross Profit/Loss - EUR | -525 | -3.006 | 1.696 | 24.626 | 7.049 | -4.764 | -13.358 | -20.031 | -4.727 | 0 |
| Net Profit/Loss - EUR | -1.274 | -3.681 | 987 | 23.462 | 6.654 | -4.925 | -13.522 | -20.121 | -4.727 | 0 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
Check the financial reports for the company - Oftaginmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 16.222 | 5.546 | 13.391 | 11.702 | 23.791 | 49.014 | 38.194 | 27.643 | 17.333 | 0 |
| Current Assets | 32.813 | 26.363 | 8.876 | 34.736 | 25.621 | 6.656 | 5.979 | 4.601 | 11.121 | 0 |
| Inventories | 10.671 | 1.947 | 0 | 0 | 1.054 | 1.034 | 0 | 0 | 0 | 0 |
| Receivables | 10.789 | 14.076 | 3.234 | 1.868 | 409 | 1.343 | 2.725 | 2.666 | 3.927 | 0 |
| Cash | 11.353 | 10.340 | 5.642 | 32.868 | 24.158 | 4.279 | 3.254 | 1.935 | 7.195 | 0 |
| Shareholders Funds | 29.082 | 25.105 | 25.667 | 48.658 | 54.370 | 48.414 | 33.819 | 13.802 | 9.033 | 0 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 0 |
| Debts | 19.954 | 26.163 | 15.948 | 12.973 | 6.217 | 14.566 | 13.927 | 18.442 | 19.421 | 0 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Oftaginmed Srl